Search results
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Motley Fool· 1 year agoBritish drugmaker AstraZeneca (NASDAQ: AZN) and U.S.-based Ionis Pharmaceuticals (NASDAQ: IONS) have...
The Stock-Split Stock Behind Ozempic and Wegovy Could Be Yours for Just $100
Motley Fool· 7 months agoIt's probably safe to assume that you've seen a commercial or heard a catchy jingle for any (if not...
Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More
Zacks via Yahoo Finance· 9 months agoThe FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo...
Dow Jones Futures Fall As Market Retreat Gains Steam; Elon Musk Makes This FSD Move
Investor's Business Daily· 2 years agoDow Jones futures fell sharply Monday morning, along with S&P 500 futures and Nasdaq futures, with...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
Zacks via Yahoo Finance· 11 months agoThis week, AstraZeneca AZN, Sanofi SNY and AbbVie ABBV and Roche announced second-quarter earnings....
IBD Stock Of The Day: How These Issues In 2023 Could Spark, Or Slam, Eli Lilly Stock
Investor's Business Daily· 1 year agoEli Lilly is the IBD Stock Of The Day as the company explores new methods of treating Alzheimer's...
Dow Jones Futures Rise As Key Economic Signal Rebounds; Tesla Rivals In Buy Zones
Investor's Business Daily· 2 years agoDow Jones futures rose modestly Thursday morning, along with S&P 500 futures and Nasdaq futures. The...
Could This New Drug Launch Be a Hit for Viatris?
Motley Fool· 1 year agoLast December, Viatris (NASDAQ: VTRS) and Kindeva Drug Delivery lost in court against AstraZeneca (NASDAQ: AZN) over a patent dispute regarding one of...
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Investor's Business Daily· 2 days agoRegeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug,...
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
Motley Fool· 10 months agoWhen Joe Biden ran for president in 2020, he promised to allow Medicare to negotiate directly with...